Effects of Chronic Restraint Stress on Aromatase, Estrogen Receptors, Inflammatory Markers and Local Estrogen Production in Brain by RAO, DI
Title  
EFFECTS OF CHRONIC RESTRAINT STRESS ON AROMATASE, ESTROGEN 
RECEPTORS, INFLAMMATORY MARKERS AND LOCAL ESTROGEN 
PRODUCTION IN BRAIN 
 
  
 
By 
Di Rao 
BS Pharmacy, China Pharmaceutical University, 2017 
 
 
  
Submitted to the Graduate Faculty of 
  
School of Pharmacy in partial fulfillment 
  
of the requirements for the degree of 
  
Master of Science 
 
 
 
University of Pittsburgh 
  
2019 
UNIVERSITY OF PITTSBURGH 
  
SCHOOL OF PHARMACY 
  
 
  
This thesis/dissertation was presented 
  
by 
  
  
Di Rao 
  
It was defended on 
  
March 13, 2019 
  
and approved by 
  
Robert B. Gibbs, Professor, Pharmaceutical Sciences 
  
M. Beth Minnigh, Assistant Professor, Pharmaceutical Sciences 
  
Shilpa Sant, Assistant Professor, Pharmaceutical Sciences 
  
Thesis Advisor/Dissertation Director: Robert B. Gibbs, Professor, Pharmaceutical Sciences 
 
  
  
  
  
 
 
 
 
 
Copyright © by Di Rao 
2019 
 
 
 
 
 1 
Abstract 
Effects of Chronic Restraint Stress on Aromatase, Estrogen Receptors, Inflammatory 
Markers and Local Estrogen Production in Brain 
  
  
Di Rao, BS Pharmacy  
  
University of Pittsburgh, 2019 
  
 
Our goal is to identify factors that underlie sex dimorphisms in the risk of developing 
psychological disorders. Numerous studies demonstrate that stress is an important contributing 
factor. Chronic stress can induce an inflammatory response in the brain, presumably via the 
activation of microglial cells. Microglial cells are macrophage-like cells in the CNS and are the 
primary cells responsible for brain immune responses. Glucocorticoids have been reported to 
stimulate microglia to transform to a pro-inflammatory state and, hence, may be a primary 
mediator of microglial response to stress. There is evidence that microglia can respond to estrogens 
which may contribute to different responses in men vs. women. Specifically, estrogens have been 
shown to inhibit the microglial inflammatory response. Brain levels of estrogens are also 
determined by local conversion of androgens via the enzyme aromatase. Brain levels of aromatase 
are higher in males than in females which can result in higher local levels of estradiol in regions 
of the male brain than in the female brain. Here, we hypothesize that stress can influence the 
activity of aromatase in the brain in a sexually dimorphic way, affecting local levels of estrogens 
in specific brain regions and resulting in sex differences in microglial activation and 
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neuroinflammatory response. We first did a pilot study focusing on the effects of chronic restraint 
stress on aromatase in the brain in a sexually dimorphic way, affecting local levels of estrogens in 
specific brain regions and resulting in sex differences in neuroinflammatory response. We 
developed a method to detect CORT levels in rat serum. Sex differences occurred in serum 
corticosterone level and CORT levels in females that had undergone daily restraint stress 
responded more to a stressor than in males. Serum E2 levels were undetectable in males and very 
low. Serum E2 levels also were undetectable in many of the females. We also detected a pattern 
suggesting sex differences in the levels of ARO-L, estrogen receptors (ERα, ERβ and GPR30) and 
inflammatory markers (IL-1ß and TNF-α) mRNA under chronic restraint stress. We did not detect 
clear changes in local estrogen levels in cerebellum, hippocampus and amygdala. Larger sample 
sizes are needed to further examine the hypothesis.  
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1.0 INTRODUCTION  
1.1 Stress is a contributing factor that underlies sex dimorphisms in the risk of 
developing psychological disorders 
1.1.1  Stress increases risk for mental illness and induces an inflammatory response 
Psychiatric illness, which includes depression, personality disorders, such as borderline 
personality disorder (BPD), anxiety disorders, schizophrenia, addictive behaviors and more [1], is 
a serious problem. In a given year, nearly one in five (19 percent) of U.S. adults ages 18-44 
experience some form of psychiatric illness [2]. The effects of mental disorders continue to grow 
with significant influence on health and economic consequences all over the world. Over hundreds 
of billions of dollars is used annually on treating mental illness in the world and direct mental 
health care accounts for approximately 10% of medical costs, and 20% of state and local health 
care costs [3, 4]. About 80% of people in low- and middle-income countries and 40% of people in 
high-income countries with mental disorders receive no treatment [5]. More effort is needed to 
understand the factors that contribute to risk for psychiatric illness and to effective methods of 
prevention and treatment.  
Sex and gender differences in mental disorders are among the most intriguing and stable 
findings in psychiatry. It is well known that certain types of psychological illnesses are associated 
with a strong sex difference in risk. For example, women have a higher lifetime prevalence of 
mood or anxiety disorders than men and a later onset of schizophrenic psychoses [6]. In contrast, 
some other disorders are much more common in men, such as alcohol dependence, which is twice 
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as high in men as in women, and antisocial personality disorder, which is three times more common 
in men than in women [7]. However, we still do not really understand the causes of these 
differences, and comparatively little research has been done to explain them. Therefore, we are 
interested in searching for the factors that underlie sex dimorphisms in the risk of developing 
psychological disorders. 
Numerous studies demonstrate that stress is an important contributing factor. Many 
preclinical studies demonstrate that under acute or chronic stress exposure, the immune system 
becomes activated resulting in the expression of cytokines, chemokines, or other molecules known 
to invoke inflammatory processes in rats and mice, including in the brain. For example, 
interleukin-1β (IL-1) and tumor necrosis factor alpha (TNFα) levels in rat brain hippocampal 
microglia are increased after inescapable shock stress [8] and are proinflammatory cytokines. 
What’s more, lots of stress models including restraint or immobilization stress, water avoidance, 
and forced swimming stress, have been shown in rats and mice to induce brain inflammatory 
responses and contribute to measures of mental illness [9]. Researchers in the field of 
psychoneuroimmunology (PNI) study relationships between the immune system and people's 
mental and emotional health. They have concluded that chronic stress can contribute to mental 
illness such as depression and anxiety. For example, a report in 2016 states that stressful 
experiences during childhood can increase levels of cytokines in brain which in turn increased risk 
of mental illness in adulthood [10]. It is also well known that some connections have been 
established between stress and neurological diseases such as neurodegenerative disorders, 
Alzheimer’s and Parkinson’s Disease [11]; Depressive Disorder [12] and Post-traumatic Stress 
Disorder [13]. Collectively, these studies show that stress can increase the risk for psychiatric 
illness and induce inflammatory response in the brain. 
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1.1.2  Microglia play a major role in Inflammatory responses in brain and GCs are 
mediators of stress and can cause microglial activation. 
Microglial cells are macrophage-like cells in the CNS and are the primary cells responsible 
for brain immune responses [14]. In their resting state, microglia have a highly branched, ramified 
morphological phenotype [15] and are dispersed throughout the CNS [16]. These branches produce 
large surface area and have dynamic motility to sense and monitor the environment. In response 
to stress, microglia can undergo a dramatic morphological transformation [17] to an amoeboid 
shape with more branches and the release pro-inflammatory cytokines. This is called microglial 
activation. The innate CNS immune system acts differently through pathogen-associated 
molecular patterns (PAMPs) and danger associated molecular patterns (DAMPs) [18]. To better 
classify the function of microglia, they are divided into two subtypes which include a pro-
inflammatory M1 state and an M2 anti-inflammatory state [19]. Preclinical studies suggest that in 
response to injury or infection, microglia can be activated to an M1 (pro-inflammatory) state where 
they release inflammatory cytokines [18] including interleukin-1β (IL-1ß), interleukin-6 (IL-6) 
and tumor necrosis factor alpha (TNFα). There is compelling evidence that IL-1ß and TNFα are 
primarily synthesized by activated microglia levels ([20][21]) in rat brain. Microglia also are 
involved in neuroprotective responses to reduce tissue damage (M2 state) in the brain [22]. Studies 
have shown that the function of microglia can change from neuroprotection to pro-inflammatory 
when exposed to acute or chronic stress.  
Chronic stress has also been shown to induce an inflammatory response in the brain, 
presumably via the activation of microglial cells. A study demonstrated that when animals were 
exposed to 10 days of variable stress and then received an intra-cortical injection of 
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lipopolysaccharide (LPS), there was significantly greater levels of MHCII expression which is 
expressed predominately on activated microglia. [23]. In human studies, microglia cells have been 
observed in the brain parenchyma from the early stage of development to the mature state and act 
as brain macrophages when programmed cell death occurs during brain development or when the 
CNS is injured or pathologically damaged. Increases in the expression of markers of microglia are 
widely reported in brains from patients with Alzheimer’s disease [24]. Collectively, these studies 
show under stress exposure, microglial cells are the primary cells which are responsible for brain 
immune responses. 
  
1.1.3  Glucocorticoids have been reported to mediate microglial cell’s pro-inflammatory 
responses to stress  
  
 Notably, glucocorticoids (GCs) have been reported to be stress hormones which mediate 
and prime microglia cell pro-inflammatory responses [25]. In a series of animal studies, 
adrenalectomized rats were treated with CORT either in their drinking water [26] or through 
subcutaneously implanted osmotic pumps or pellets [27][8]for two weeks and were exposed to 
stress. The results show elevated CORT levels also increased the gene expression of NLRP3, Ibα-
I and MHCII [28]in a concentration dependent manner [27] which shows that CORT can increase 
inflammatory responses in the brain. Other results show that elevated CORT levels exacerbate 
stress effects on NF-kB, MAP kinases, and pro-inflammatory gene expression [26]. In humans 
there is evidence for cause-effect relationships between prolonged stress, elevated GC levels, and 
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cognitive and mood disorders while the evidence for a link between chronic stress, GCs, and 
neurodegenerative disorders such as Alzheimer’s (AD) and Parkinson’s (PD) diseases is growing 
[29]. These results suggest that chronic exposure to CORT mediates microglial transformation to 
a pro-inflammatory state and induces downstream signaling pathways in response to stress. 
1.2  Estrogens are produced locally in the brain and are associated with sex 
differences in the risk for psychiatric illness 
The sexual dimorphisms observed in certain types of psychiatric illness may be associated 
with different levels of sex hormones (estrogens) in the brains of females and males. In vivo and 
in vitro studies [30] have shown sexually dimorphic differences remain in rat brain microglial 
inflammatory responses when stimulated with an immune challenge. When male and female rat 
microglia cells were isolated and incubated with varying doses of E2, the E2 produced anti-
inflammatory effects in the male microglia but a pro-inflammatory effect in female microglia in 
response to LPS [31][32]. Studies reported estrogen can activate nuclear estrogen receptors (ERs), 
ERα and ERβ [33] and regulate gene transcription and activate second messenger signaling 
pathways. A report also identified a novel membrane-associated estrogen receptor GPR30 [34], 
which is located both intracellularly and on the plasma membranes and plays a very important role 
in mediating estrogen effects in the brain [35, 36]. What’s more, other studies also revealed that 
estrogens and estrogen receptor (ERα, ERβ and GPR30) agonists can reduce activation of 
microglia under stress and significantly decrease inflammatory response [37][38]. Therefore, 
estrogens can reduce inflammatory responses and cause sex differences in microglial responses 
under stress exposure.  
 16 
Brain aromatase, composed of CYP19A1 and NADPH, is a local enzyme which 
irreversibly converts androgens (both androstenedione and testosterone) to estrogens (estrone and 
E2). There are two forms in the brain, a long form aromatase which is associated with ARO 
activity, and a short form (ARO-S) with no known function [39]. Therefore, we focused on 
detecting long form aromatase mRNA expression. In past years, research of ARO in the brain has 
mainly focused on its function to regulate sexual dimorphism and roles in neuroprotection [40, 
41][42][43]. It is well known that males have more circulating levels of androgens than females, 
and aromatase will produce higher local levels of estrogens in the male brain than in the female 
brain. We hypothesize that the higher levels of estrogens produced locally in the brain can reduce 
microglial inflammatory responses and thus produce sex difference in females and males. 
Therefore, estrogens which are produced locally in the brain are factors which may contribute to 
sex differences in the risk for psychiatric illness. 
  
1.2.1  Evidence that stress can influence ARO expression and E2 production in the brain 
In quails, there are studies showing that ARO activity and E2 levels in the preoptic area 
(POA) of the brain were increased by acute stress in males [40, 44]; however, the circulating levels 
of testosterone and estradiol were unchanged in response to acute stress. The results suggested 
under stress exposure, sex differences occur due to ARO activity and local E2 levels in the quail 
brain. 
However, in mammalian studies, less is known about the effects of ARO activity partly 
due to difficulty in measuring E2 in the brain. Recently, our lab has developed a reliable assay for 
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measuring E2 levels in different regions of the brain using UPLC-MS/MS methods [45]. Data 
show that in brain regions with significant ARO activity (e.g., hippocampus, amygdala), local 
levels of E2 can greatly exceed circulating levels in both males and females [46].  Data from our 
lab also showed significant levels of E2 in these same brain regions in male rats, confirming that 
local E2 synthesis plays an important role in determining E2 levels in the brain in both sexes. 
1.3 Overview of thesis   
 The purpose of this project is to investigate whether estrogens produced locally in the brain 
can be associated with sex differences in the risk for stress-related brain/ neuroinflammatory 
response. If that is true, it may provide a possible mechanism to explain sex dimorphisms in the 
risk of developing psychological disorders. Here we hypothesize that chronically elevated stress 
hormone (i.e., corticosterone), can influence the activity of aromatase in the brain in a sexually 
dimorphic way, affecting local levels of estrogens in specific brain regions and resulting in sex 
differences in microglial activation and neuroinflammatory response. To examine this hypothesis, 
our lab entered into a collaboration with Dr. Cheryl Conard at the Arizona State University to 
conduct a pilot study. The pilot study focused on effects of chronic restraint stress on aromatase, 
estrogen receptors, and inflammatory markers in brain. Here we hypothesize that chronic restraint 
stress can influence the activity of aromatase in the brain in a sexually dimorphic way, affecting 
local levels of estrogens in specific brain regions and resulting in sex differences in 
neuroinflammatory response. Specific goals were as follows: 1) to determine whether chronic 
restraint stress can influence brain neuroinflammatory response and aromatase expression in a 
sexually dimorphic way 2) test specifically whether local estrogen production is associated with 
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sexually dimorphic effects of chronic restraint stress on inflammatory response in the brain. These 
goals are described in greater detail in the following chapters.      
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2.0 METHOD DEVELOPMENT 
In this project, we hypothesize that chronic restraint stress can influence the activity of 
aromatase in the brain in a sexually dimorphic way, affecting local levels of estrogen production 
in specific brain regions and resulting in sex differences in neuroinflammatory response. To 
measure changes in the levels of ARO-L, estrogen receptors (ERα, ERβ and GPR30) and 
inflammatory markers (IL-1ß and TNFα) mRNA, we performed quantitative real time reverse 
transcription PCR (q-RT-PCR) and checked RNA quality by gel electrophoresis. As part of our 
studies, this method was validated to have a wide detectable range, high specificity and 
reproducibility. To test the changes in E2, T and CORT levels in rat serum and local E2 production 
in different rat brain regions, we developed a method to measure CORT based on methods 
previously developed in our lab for measuring E2 and T using UPLC-MS/MS. This method was 
also validated to be sensitive and reproducible. Details of these methods are described below:  
2.1 Q-RT-PCR method for comparing relative levels of ARO-L, estrogen receptors 
and Inflammatory markers mRNA 
2.1.1  Description of q-RT-PCR method  
Collection of tissues, extraction of mRNA and preparation of cDNA:    
These series of methods have been developed in our lab [46]. Rats were anesthetized. 
Brains were removed and tissues from the hippocampus, cerebellum, medial prefrontal cortex and 
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amygdala were dissected. Each brain region was put into 1.5ml tube and weighed. Each piece of 
tissue was sonicated in 100mg/ml TRIzol (Invitrogen, Inc.) at 4˚C and then incubated for 5 min at 
room temperature. The homogenate was mixed with chloroform (250ul/1ml homogenate), 
incubated for 2 min, at room temperature and centrifuged at 4℃ ,12,000xg for 15min.The 
supernatant was collected, and an equal volume of isopropyl alcohol was added to precipitate 
nucleic acids. Nucleic acids were incubated for 10 min, washed with 70% ethanol and pelleted by 
centrifugation (4℃,12,000xg for 15min). The pellet was dissolved in DEPC water for 10 min at 
42˚C. residues were then digested by adding DNAse enzyme (10U/µl), RNA enzyme inhibitor 
(40U/ul), 25mM MgCl2 and PCR buffer and incubating for 30 minutes in 37℃ water bath. The 
remaining RNA was re-extracted with phenol-chloroform and precipitated with sodium acetate 
and ETOH. The concentration of RNA was determined by spectrophotometry using a Nanodrop 
2000 (Thermo Scientific). mRNA was then reverse transcribed to cDNA using the SuperScript III 
kit (Invitrogen, Inc.) as per manufacturer’s recommendations.  
qPCR Method: 2µl of cDNA, 10µl of SYBR Green, and 1.2µl primer pair was pipetted to each 
well of a 96-well plate (0.1mL/well). The primer pairs are summarized in Table 1. 
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Table 1 The sequence of target mRNA primer pairs 
 
  
These primer pairs were validated by Genebank primer-BLAST. The product of the GAPDH 
primer is 85bp length and is located on exon 6 of the GAPDH gene. PCR was conducted using the 
QuantStudio™ 3 - 96-Well 0.1 mL Block (ThermoFisher), with an initial step at 50 ˚C for 2 min
，95 ˚C for 10 mins and 15 s, then 40 cycles of 60 ˚C for 1 min. At the end of the ampliﬁcation, 
samples were set to 95˚C for 15s 60 ˚C for 30s, and 95˚C for 15s to obtain the melt curve. Data 
were analyzed using QuantStudio™ 3 software (ThermoFisher), and results were obtained as Ct 
(threshold cycle number) values. The effects of treatment on relative long-form aromatase (ARO-
L), estrogen receptors (ERα, ERβ and GPR30) and inflammatory markers (IL-1ß and TNFα) 
mRNA levels were calculated using the following formula [47]:  
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[47] 
 Two-way ANOVA was used to analyze the differences between group means. Tukey HSD 
was used to determine significant differences in expression between stress and control groups in 
females and males.   
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2.1.2  Validation of q-RT-PCR method 
 
Figure 1 Validation of q-RT-PCR method: (A) Agarose gel illustrates the size of DNA products produced by 
PCR amplification using IL-1ß and TNFα  primer pairs. (B) Dilution curve showing change in Ct for 
detection of IL-1ß mRNA. (C) Dilution curve showing the changes in Ct for detection of TNFα mRNA. 
 
  
 
Product validation: Our lab had already validated ARO-L primer pairs, estrogen receptors 
primer pairs and control gene GAPDH primer pairs. To verify whether inflammatory markers (IL-
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1ß and TNFα) primer pairs we amplified a product of the expected size, we ran the product on an 
1.0% agarose gel. 1µl 100bp DNA ladder mixed with 2µl 6x Gel Loading buffer was loaded in 
one lane and was used to identify the size of the product. As the result shows in Figure1 (A), the 
product of IL-1ß primer pair is approximately 137bp length and the product of TNFα primer pair 
is approximately 109bp length as predicted. No other bands from these two primer pairs were 
detected, which suggests that these primer pairs for IL-1ß and TNFα specifically amplify IL-1ß 
and TNFα sequences as predicted.   
Linear range: To find out the linear range of q-RT-PCR method, we did a serial dilution of 
the cDNA sample and used IL-1ß or TNFα primer pairs to test the cycle number change. Figure 
1(B) and (C) show that each showed a linear relationship between dilution and cycle number in 
the range of 26 to 32 cycles (Y = 1.051*X + 26.47 R=0.9787, F(1,4)=184.5, P=0.0002<0.05) for 
IL-1ß and 24 to 32 cycles (Y = 1.227*X + 24.64,R=0.995, F(1,4)=798.6, P<0.0001) for TNFα, 
which suggests that q-RT PCR method is able to quantify changes in relative levels of IL-1ß and 
TNFα mRNA up to 32 cycles.  
Reproducibility: We also tested the reproducibility of the q-RT-PCR method by calculating 
the coefficient of variation of both IL-1ß and TNFα. To do this, identical samples were analyzed 
in different wells of the plate. This experiment was repeated and the coefficient of variation (CV) 
was calculated for each run and each primer pair. Both the CV for IL-1ß and TNFα primer pairs 
were less than 2%, which suggests that the method has good reproducibility (data not shown).  
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2.1.3  Validation of RNA quality ---- RNA Gel Electrophoresis  
RNA-based bioanalysis requiring high-quality, non-degraded RNA are a foundational 
element of many research studies. The integrity of experimental RNA is validated through an RNA 
Gel Electrophoresis [48] (“bleach gel”) which is a modified method from DNA gel electrophoresis 
in 2.1.2. 1.0% v/v commercial chlorine bleach (6% sodium hypochlorite; Clorox®, Oakland, CA) 
was added to a standard TAE agarose gel and filled completely with 1x TAE buffer. Each gel was 
loaded with samples consisting of 1x DNA loading buffer (DNA Loading Dye), prepared from a 
10x DNA loading buffer stock and 1µg of total RNA isolated from sample in both first and second 
shipment. The gels were run for 35 minutes with constant voltage (100 V) prior to imaging under 
UV transillumination. 
2.2 Method for detecting local E2 production in different brain regions and E2, T 
and CORT levels in serum 
2.2.1  E2 and T detection  
Our lab has already developed and validated the assay for detecting T levels in the serum 
and E2 levels in both serum and brain tissue homogenates using UPLC-MS/MS, which have been 
proved to be extremely accurate [45, 46]. 
UPLC–MS/MS was used to quantify E2 in the serum and brain tissue homogenates. Brain 
tissue was homogenized in potassium phosphate buffer (0.12 M, pH 7.4) containing 4.0 mM 
MgCl2, 4.0 mM Tris and 50 mM sucrose (100 mg tissue/ml). E2 was then measured in 
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homogenates and serum as recently described [45]. Briefly, samples were spiked with internal 
standard 25µl 2,4,16,16,17-d5-17 beta-estradiol (1 ng/ml in methanol, LC grade). 3-4 ml n-butyl 
chloride (Sigma-Aldrich, Inc.) was added and samples were vortexed for 1 min. Samples were 
then centrifuged at 4000 rpm at room temperature (RT) for 10 min, and the organic layer was 
transferred to sanitary culture tubes and dried under a stream of nitrogen at 37 ˚C for 20 min. 
Residues were derivatized in 0.1 ml buffered dansyl chloride solution (0.5 mg/ ml, a 1:1 mix of 
acetonitrile: water, pH 10.5, LC grade, Sigma-Aldrich, Inc.) in sanitary tubes and heated to 60 ˚C 
for 3 min. Samples were centrifuged again for 1 min at 490 x g, and the supernatant (∼0.1 ml) was 
transferred into glass vials for UPLC–MS/MS analysis with an injection volume of 7.5µl. 
Calibration curves were prepared at concentrations of 0.009, 0.018, 0.036, 0.09, 0.18, 0.36 and 
0.72 pmol/ml and quality controls (QCs) at 0.01 and 0.10 pmol/ml in a matrix of 0.2% 2-
hydroxypropyl-β-cyclodextrin (HPCD). Studies demonstrating the validity of using HPCD as the 
matrix for the standards and QCs were conducted and are described below. Calibration curves and 
QCs were extracted and derivatized at the same time as the tissue and serum samples. E2 was 
eluted using a Waters Acquity UPLC BEH C18, 1.7µm, 2.1 × 150 mm reversed-phase column, 
with an acetonitrile: water (0.1% formic acid) gradient. MS Detection and quantification were 
achieved in the positive mode. Transitions used for analysis were 506 → 171 for E2, and 511 → 
171 for the deuterated internal standard. Tests show that this assay can reliably distinguish 17-β-
estradiol (E2) from 17-α-estradiol and estrone, based on retention time. To calculate E2 level in 
the tissue and compare it with the serum level, we equated 1 g tissue to 1 ml water. 500ul serum 
was used to measure serum E2 level. The E2 concentration in both brain tissue and serum were 
calculated as pmol/ml. Inter-day and intra-day precision and accuracy of this assay have been 
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described [45] and are within acceptable limits. The limit of detectability for this assay is 0.009 
pmol/ ml.  
T levels in serum and brain homogenates were quantified by a modification of the method 
described by Cawood et al. and using UPLC–MS/MS similar to the E2 detection method described 
above. Briefly, 350ul serum were spiked with 0.25 ng/ml D3- testosterone (Sigma-Aldrich, Inc.) 
as the internal standard and then extracted with 3 ml n-butyl chloride. After centrifugation and 
evaporation, the residue was reconstituted in methanol and water (80µl:20µl, LC grade), 
centrifuged again for 1 min at 490×g and the supernatant was transferred into glass vials for 
UPLC–MS/MS analysis. T was eluted from the same column as E2, with a methanol: water (0.1% 
formic acid and 2 mM ammonium acetate) gradient from 50 to 85% methanol. Transitions used 
for analysis were 289 → 97 for T and 292 → 97 for the deuterated T. The ratio of area under the 
peak between T and deuterated T was quantified and used to determine levels of T pmol/ml by 
comparison with standards ranging from 0.035 pmol/ ml to 55 pmol/ml. The limit of detectability 
for this assay was 0.035 pmol/ml. The inter-day precision, accuracy and stability were within 
acceptable limits. 
2.2.2  CORT detection   
CORT levels in serum were quantified by a modification of the methods described by 
Riffle, et al. [49] and by Yucel et al. [50], and using UPLC–MS/MS similar to the T detection 
method described above. 150ul to 200ul serum were spiked with 30µl D8- Corticosterone (5µg/ml 
in methanol, LC grade) as the internal standard and then extracted with 1.5 ml n-butyl chloride. 
After centrifugation and evaporation, the residue was reconstituted in acetonitrile: water 
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(30µl:30µl, LC grade), centrifuged again for 1 min at 490×g and the supernatant was transferred 
into glass vials for UPLC–MS/MS analysis. CORT was eluted from the same column as T, with 
an acetonitrile: water (0.1% formic acid) gradient (50%:50%). MS Detection and quantification 
were achieved in the positive mode. Transitions used for analysis were 347 → 121 for CORT, and 
355 → 121 for the deuterated internal standard. The ratio of area under the peak between CORT 
and deuterated CORT was quantified and used to determine levels of CORT ng/ml by comparison 
with standards ranging from 25 ng/ ml to 500 ng/ml. The limit of detectability for this assay was 
25 ng/ml.  
Validation of UPLC-MS/MS method for quantitation of CORT: Extraction recovery. 
Figure 2 evaluated the relationship between CORT extraction and detection using HPCD as 
matrix. CORT was prepared in rat serum (0, 25, 50, 75, 100 and 200ng/ml), and in 0.2% HPCD 
(0, 25, 50, 100, 250, 500 ng/ml).  After UPLC–MS/MS analysis, values of CORT prepared in rat 
serum were calculated using CORT prepared in HPCD as calibration curve. Linear regression 
analysis revealed that observed CORT levels using HPCD as calibration curve had a significant 
linear regression with the amount CORT added into serum (Y = 1.159*X + 176.6, R2=0.9934 F 
(1,4) =601.5, P<0.0001). This shows that the extraction and detection of CORT from HPCD is the 
same as from the rat serum. Hence HPCD was used as the matrix for all calibration curves 
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Figure 2 Evaluation of brain tissue homogenate vs. HPCD as a matrix for the extraction and detection of 
CORT 
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3.0 Effects of Chronic Restraint Stress on Aromatase, Estrogen Receptors, Inflammatory 
Markers and local Estrogen production in Brain 
3.1 Overview of study design 
Figure 4 contains a flow diagram showing the experimental design. 48 young female and 
male Sprague-Dawley rats (24 females, 24 males; n=12/Tx group) were purchased by the Conrad 
Lab, Arizona State University and were acclimated for one week after arrival in that facility. Rats 
were housed in pairs on a 12 hour:12-hour light/dark schedule with unrestricted access to food and 
water. Then half of each sex was restrained for 6 hours/day for 21 days. Restraint stress occurred 
during the rats’ naturally active period. The timing of brain dissection took place the day following 
the end of chronic restraint stress (21 days). On day 22, Conrad Lab Team collected fresh brain 
tissues (bilaterally) of the hippocampus (HPC), mPFC, amygdala (AMG) and cerebellum (CB). 
The wet weight tissue for each sample was determined. Each sample was then frozen at -80°C. 
Additional measures included adrenal weights, thymus weights, uterine weights and body weights 
(the latter was collected weekly during restraint). Serum was also harvested from rat trunk blood. 
Samples were shipped to our lab in two shipments (half of each group) from Arizona. However, 
samples which were shipped first (half of each group) met a shipping problem and were delayed 
for several days during transit. We soon discovered that RNA in the first shipment sample were 
compromised and degraded because its target GAPDH cycle number increased from about 15 to 
20 which was unusual. So we checked RNA quality of the samples by RNA gel electrophoresis as 
mentioned in 2.1.3. 
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In Figure 3, we show that sample from cerebellum 3 (CB3) and cerebellum 25 (CB25) 
which shipped first and sample from cerebellum 15 (CB15) which shipped second were run on an 
RNA agarose gel. When assessing the quality of RNA by gel electrophoresis, the presence of three 
distinct bands suggests high quality RNA. For CB15, the top band represents 28S ribosomal RNA 
(rRNA) and the second band represents 18S rRNA. Though the third band which represents 5.8S 
rRNA was invisible, the two bands still suggest RNA integrity in the sample from cerebellum 15 
(CB15) which shipped second was high. But there were no bands in CB3 and CE25 which 
suggested degradation of RNA in samples which were shipped first. Taken together, this suggests 
that RNA of the samples which were shipped first were compromised and not suitable for q-RT-
PCR analysis. 
 
Figure 3 Cerebellum RNA gel electrophoresis. CB3: cerebellum3, CB25: cerebellum25, CB15: cerebellum15, 
28S: 28S ribosomal RNA, 18S: 18S ribosomal RNA. 
 
We had used 4 samples from each group in the first shipment from hippocampus, prefrontal 
cortex, amygdala, and preoptic area to detect ARO-L, estrogen receptors (ERα, ERβ and GPR30) 
and inflammatory markers (IL-1ß and TNFα) mRNA expression using the q-RT-PCR methods 
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described above in 2.1. But we quickly found the result using these samples from first shipment 
was inconclusive and had high variability (data not shown). 
 
 
Figure 4 Flow diagram showing the experimental design. M-Control: male control group, F-Control: female 
control group, M-Stress: male restraint stress treated group, F-Stress: female restraint stress treated group, 
HPC: hippocampus, AMG: amygdala, cerebellum (CB) 
 
We next proceeded to use 4 samples from each group in the second shipment from 
hippocampus, prefrontal cortex, amygdala, and preoptic area to test ARO-L, estrogen receptors 
(ERα, ERβ and GPR30) and inflammatory markers (IL-1ß and TNFα) mRNA expression using 
the q-RT-PCR methods described above. Ratios between all targets and GAPDH were calculated 
to present the relative mRNA level. All ratio values were normalized to the mean of male non-
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stressed controls. ANOVA was used to analyze the differences between group means. Tukey HSD 
was used to determine significant differences in expression between sex in stress groups and 
control. 
To detect local E2 production levels in different brain regions, we used the remaining 4 
samples per group from cerebellum, hippocampus, prefrontal cortex, and amygdala from the first 
shipment to detect local E2 production levels using UPLC-MS/MS methods described above in 
2.2. In each group, every two samples were combined and pooled to generate one point in 
hippocampus and amygdala. To detect E2, T and CORT levels in serum, 300µl serum were used 
to detect CORT level. 500µl serum were used to detect E2 level and 350µl serum were used to 
measure testosterone levels by UPLC-MS/MS assay in 2.2. Two-way ANOVA was used to 
analyze the differences between group means. Tukey HSD was used to determine significant 
differences in expression as a function of sex and stress vs. controls. 
3.2 Effects of Chronic Restraint Stress on E2, T and CORT levels in serum 
3.2.1  Results 
Figure 5 illustrates serum CORT levels in the four groups of rats. Two-way ANOVA 
showed a significant effect of sex (F [1,42] = 23.57, P<0.001). CORT levels in females were higher 
than that in males. There was no significant effect of treatment (F [1,42] = 1.32, P=0.2576) or 
treatment*sex interaction (F [11,42] = 3.89, P=0.0558). Post hoc analyses showed that CORT 
levels between stress and control groups in females and males were not statistically significant. 
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But in females, serum CORT levels in the stress group was significantly higher than in the control 
group which was nearly significant (F [11,42] = 3.89, P=0.0558). 
 
Figure 5 CORT levels in rats serum. Bars indicate the mean rats serum CORT levels ± s.e.m in M-CON: male 
control group, F-CON: female control group, M-STRESS: male restraint stress treated group, F-STRESS: 
female restraint stress treated group. N=4 for each group. * indicates the p ≤0.05 between sex. N=12 for each 
group. 
 
Serum E2 levels in rats between stress and control groups in females and males are summarized 
in Table 2. In males, E2 levels were undetectable. In females, E2 levels were very low and in 
most samples were undetectable. 
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Table 2 Serum E2 levels. Data indicate animal name and E2 level in M-CON: male control group, F-CON: 
female control group, M-STRESS: male restraint stress treated group, F-STRESS: female restraint stress 
treated group. ND indicates not detectable and - indicate indicates not detectable and - indicates insufficient 
sample for analysis. 
 
 
 
3.2.2  Discussion 
The goal of this analysis was to collect preliminary data on the effects of chronic restraint 
stress on E2, T and CORT levels in serum.  
Results from CORT level study showed that after weeks of repeated restraint stress, sex 
differences occurred in serum CORT levels, and CORT levels in females responded more to stress 
than in males. Studies [51] have reported that under chronic restraint stress in adolescence male 
and female rats, results show that males and females exhibit different CORT responses and that 
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only adult female rats exposed to stress during adolescence show higher basal CORT levels 
compared to non-stressed controls. Our study replicated this result. Our results also reported that 
treatment had no effects on serum CORT level and the basal serum CORT level seems higher. But 
in Dr. Conrad’s lab [52], they reported that chronic restraint stress did not elevate baseline CORT 
levels in serum. But CORT levels increased within 30-min from the start of restraint stress across 
all days measured and then they returned to baseline on all but the first day of restraint stress.  
It is important to note that levels of CORT were elevated at sacrifice, indicating a stress 
response. The elevated levels of CORT in rat serum at sacrifice are due to the stress associated 
with the method of sacrifice. When the rats were sacrificed, the method which we use were 
regarded as a way of stressing and exposed to such stress, rats CORT levels were elevated. 
Serum E2 levels were undetectable in males and very low, even undetectable in most 
females. We had verified our assay to be sensitive and reliable for measuring E2 levels by UPLC-
MS/MS [45, 46]. Therefore, it is not likely our assay failed. As it has been reported [53] E2 is 
secreted across the estrous cycle in the female rats. E2 levels are low during diestrus (Day1) and 
at day2 begin to rise at the end of diestrus. It reaches the peak in late proestrus (P), and then drops 
to baseline levels during estrus (E). Behavioral changes associated with estrus occur during the 
dark phase. It is possible that female rats were sacrificed during diestrus; resulting in the low E2 
levels.  
We also attempted to measure serum T levels (data not shown); however, the method for 
measuring T levels failed. At first, we met a T contamination in the UPLC-MS/MS system. Later 
we solved this problem but found the background of T level was very high. We also have not 
enough amount of serum to retest T level again. Therefore, the data were not trustable and we were 
not able to measure T levels in the rat serum. 
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3.3 Effects of Chronic Restraint Stress on Aromatase, Estrogen Receptors, and 
Inflammatory Markers in different Brain regions between females and males 
3.3.1  Effects of Chronic Restraint Stress on relative levels of ARO-L mRNA in different 
brain regions between females and males 
 
Figure 6 Effect of chronic restraint stress on long form ARO mRNA expression in (A) Hippocampus, (B) 
mPFC, (C) Amygdala,(D) Cerebellum.  Bars indicate the mean fold changes of long form ARO mRNA 
relative to male control group ± s.e.m. after normalizing to GAPDH. M-CON: male control group, F-CON: 
female control group, M-STRESS: male restraint stress treated group, F-STRESS: female restraint stress 
treated group. * indicates significant difference (p < 0.05) in female control group ARO-L mRNA expression 
in HPC compared to male restraint stress treated group. $ indicates significant difference (p < 0.05) in to 
male restraint stress treated group ARO-L mRNA expression in HPC compared to female restraint stress 
treated group. N=4 for each group 
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Results: 
The effect of chronic restraint stress on long-form ARO mRNA expression in different 
brain regions between females and males is summarized in Figure 6.  
In hippocampus, two-way ANOVA revealed a significant effect of sex (F[1,10] = 5.35, 
p<0.05) and a significant effect of stress (F[1,10] =7.22, p<0.05), but no stress*sex interaction 
(F[1,10]=1.18, p=0.3). Post hoc analyses suggests that long-form ARO mRNA expression in 
female controls was not significantly different from female stress group or male control group but 
was significantly lower than male stress group. 
In mPFC, two-way ANOVA revealed a significant effect of sex (F[1,10]=6.12, p<0.05) 
and a significant effect of stress*sex interaction (F[1,10]=5.34, p<0.05), but no effect of stress 
(F[1,10]=0.78, p=0.4). Post hoc analyses suggests that, long-form ARO mRNA expression in male 
controls was not significantly different from female controls and female stress group that levels 
were significantly lower in male stress group vs. all other groups.  
In amygdala, two-way ANOVA revealed no significant effects of sex (F[1,9]=0.12, 
p=0.74), stress (F[1,9]=0.82, p=0.39) or stress*sex interaction (F[1,9]=1.23, p=0.30) on long-form 
ARO mRNA expression.  
In cerebellum, two-way ANOVA revealed no significant effects of sex (F[1,9]=0.85, 
p=0.38), stress (F[1,9]=0.28, p=0.60) or stress*sex interaction (F[1,9]=1.03, p=0.33) on long-form 
ARO mRNA expression. 
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Discussion:  
Figure 6 evaluated the effects of chronic restraint stress on relative levels of ARO mRNA 
between females and males in different regions of the brain. This was done to explore patterns 
about the effects of chronic restraint stress on aromatase mRNA expression in different regions of 
the brain in both males and females. It would give us the first step to examine our hypothesis that 
stress can influence the activity of aromatase in the brain in a sexually dimorphic way.   
Our study is a pilot study and the sample sizes are small (four animals each group). As a 
result, the power analysis is limited and more numbers of animals in each group are needed to 
generate a meaningful conclusion in statistical analysis. Because we use delta-delta Ct method to 
quantify changes in relative levels of mRNA between groups, any changes in relative levels of 
mRNA more than 2-fold are believed to have some biological significance. Therefore, we can still 
get meaningful information by looking at patterns between groups though they were not 
statistically significant. 
Our results suggest that in hippocampus, chronic restraint stress results in 30% and 50% 
elevated levels of ARO mRNA expression in stress groups than in control groups in both females 
and males. Females in mPFC and males in CB also had same patterns (30% elevation). In contrast, 
males in mPFC (70% decrease) and females in amygdala and cerebellum (50% decrease) have 
opposite patterns. Taken together, our results present a pattern indicating under chronic restraint 
stress, sex differences occurred on relative levels of ARO mRNA expression and treatment of 
stress also can alter ARO-L expression in different brain regions. 
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Only a few reports have been known to examine the effect of stress on aromatase in the 
brain using rodent models. Most researchers examine the effects of stress on aromatase expression 
using birds or fish models since E2 synthesized in the brain plays a critical role in the activation 
of sexual behavior in many vertebrate species and levels of E2 synthesized in the avian and 
amphibian brain are high [54]. Dickens et al. reported acute stress differentially affects aromatase 
activity in specific brain nuclei of adult male and female quail [40]. There is a paper which reported 
postmortem material from patients with Alzheimer's disease (AD) and in a mouse model for AD 
(5xFAD mice) [43] suggesting that hippocampal ARO expression may change in response to 
Alzheimer's disease in both humans and mice and supports the idea that brain-derived E2 has 
neuroprotective function. The sex differences found in the mouse model indicates that the 
neuroprotective role of brain-derived estradiol may be more important in females than in males 
and may help to explain why women are more prone to the disease than men [43]. Bender, RA 
[55] reported that the basolateral amygdala (BLA), a key structure of the fear circuit, has a sexually 
dimorphic regulation of synaptic plasticity involving neuronal aromatase, which produces the 
neurosteroid 17β-estradiol (E2). These findings could be relevant for the understanding of sex 
differences in mood disorders [55]. These findings appear to be in accordance with our finding 
that ARO expression can be altered by stress. But more data is needed. 
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3.3.2  Effects of Chronic Restraint Stress on relative levels of Estrogen Receptors in 
different brain regions between females and males 
 
Figure 7 Effect of chronic restraint stress on estrogen receptors (ERα,ERβ and GPR30) mRNA expression in 
(A) Hippocampus, (B) mPFC, (C) Amygdala,(D) Cerebellum. Bars indicate the mean fold changes of estrogen 
receptors (ERα, ERβ and GPR30) mRNA relative to male control group ± s.e.m. after normalizing to 
GAPDH. M-CON: male control group, F-CON: female control group, M-STRESS: male restraint stress 
treated group, F-STRESS: female restraint stress treated group. . * indicates significant difference (p < 0.05) 
in AMG ERβ mRNA expression between sex. $ indicates a significant effect of treatment × sex interaction (p 
< 0.05) in AMG and CB GPR30 mRNA expression. N=4 for each group. 
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Results:  
The effect of chronic restraint stress on estrogen receptors (ERα, ERβ and GPR30) mRNA 
expression in different brain regions between females and males is summarized in Figure 7.  
In the amygdala, two-way ANOVA revealed no significant effects of sex (F[1,11]=0.88, 
p=0.36), stress (F[1,11]=0.25, p=0.62) or stress*sex interaction (F[1,11]=2.34, p=0.15) on ERα 
mRNA expression. Two-way ANOVA revealed a significant effect of sex (F[1,8]=8.02, p<0.05), 
no significant effects of stress (F[1,8]=2.02, p=1.85) or stress*sex interaction (F[1,8]=0.92, 
p=0.35) on ERβ mRNA expression. Two-way ANOVA revealed a significant effect of stress × 
sex interaction (F[1,9]=7.89, p<0.05), no significant effects of sex (F[1,9]=1.89, p=0.19) or stress 
(F[1,9]=0.44, p=0.52) on GPR30 mRNA expression. 
 In cerebellum, two-way ANOVA revealed no significant effects of sex (F [1,10]=0.38, 
p=0.55), stress (F[1,10]=2.65, p=0.13) or stress*sex interaction (F[1,10]=0.15, p=0.70) on ERα 
mRNA expression. Two-way ANOVA revealed no significant effects of sex (F[1,11]=0.06, 
p=0.80), stress (F[1,11]=0.51, p=0.49) or stress*sex interaction (F[1,11]=0.41, p=0.53) on ERβ 
mRNA expression. Two-way ANOVA revealed a significant effect of stress × sex interaction 
(F[1,11]=6.32, p<0.05), no significant effects of sex (F[1,11]=3.12, p =0.10) or stress 
(F[1,11]=2.32, p=0.15) on GPR30 mRNA expression.  
In hippocampus, two-way ANOVA revealed no significant effects of sex (F[1,12]=3.90, 
p=0.07), stress (F[1,12]=3.18, p=0.08) or stress*sex interaction (F[1,12]=0.03, p=0.86) on ERα 
mRNA expression. Two-way ANOVA revealed no significant effects of sex (F[1,10]=0.28, 
p=0.6), stress (F[1,10]=0.04, p=0.84) or stress*sex interaction (F[1,10]=3.72, p=0.08) on ERβ 
mRNA expression. Two-way ANOVA revealed no significant effects of sex (F[1,11]=0.10, 
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p=0.75), stress (F[1,11]=0.03, p=0.85) or stress*sex interaction (F[1,11]=0.21, p=0.65) on GPR30 
mRNA expression.  
In mPFC, two-way ANOVA revealed no significant effects of sex (F[1,12]=1.14, p=0.30), 
stress (F[1,12]=2.31, p=0.15) or stress*sex interaction (F[1,12]=0.11, p=0.74) on ERα mRNA 
expression. Two-way ANOVA revealed no significant effects of sex (F[1,11]=0.02, p=0.88), stress 
(F[1,11]=2.31, p=0.15) or stress*sex interaction (F[1,11]=0.49, p=0.48) on ERβ mRNA 
expression. Two-way ANOVA revealed no significant effects of sex (F[1,12]=0.57 p=0.46), stress 
(F[1,12]=0.16, p=0.69) or stress*sex interaction (F[1,12]=0.46, p=0.50) on GPR30 mRNA 
expression. 
 
Discussion:  
The goal of this experiment was to collect data on the effects of chronic restraint stress on 
estrogen receptors (ERα, ERβ and GPR30) expression in different brain regions between females 
and males.  
Our results indicate that in hippocampus, chronic restraint stress results in 40% and 30% 
elevated levels of ERα expression in stress groups than in control groups between both females 
and males. In contrast, males in amygdala (50% decrease) and males and females in both mPFC 
and cerebellum (25% decrease) have opposite patterns. Taken together, our results indicate a 
pattern suggesting under chronic restraint stress, sex differences occurred on relative levels of ERα 
mRNA expression and treatment of stress also can alter ERα expression in different brain regions.  
For ERβ mRNA expression, the results indicated that males in hippocampus (50% 
decrease), mPFC (50% decrease) and amygdala (70% decrease), chronic restraint stress results in 
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decreased levels in stress groups than in control groups. In contrast, chronic restraint stress caused 
30% elevated levels of ERβ expression in stress groups than in control groups in the female rats 
in hippocampus. What’s more, in amygdala, the results suggested that chronic restraint stress 
resulted in 50% decreased levels in stress groups than in control groups, but at the same time, 
caused 90% elevation in GPR30 expression in stress groups than in control groups. 
    Reports from other laboratories about the effects of stress on estrogen receptor 
expression in the brain have been inconsistent. Some researchers used primary microglia, 
microglial cell lines, and vivo models to study the expression of ERs. But ER expression remains 
unclear. ERβ expression was shown to increase in monkey microglia during ischemia [56]. Sierra 
et al. demonstrated the presence of ERα in adult microglia, implying they are a direct target of 
steroid hormones, but not ERβ [57]. The expression of ERs in microglia is believed to depend on 
species and culture conditions and is thought to be regulated by a variety of stressful stimuli [37]. 
However, Byerly etal. [58] reported estrogen-related receptor β deficiency alters body composition 
and response to restraint stress. This result indicates that ERβ alters the function of the 
hypothalamic-pituitary-adrenocortical axis and indicates a role for ERβ in regulating stress 
response [58]. At this point, our data on ERβ expression is consistent with the report. But again, 
more data are needed to see the changes between each group. 
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3.3.3  Effects of Chronic Restraint Stress on relative levels of Inflammatory markers (IL-1ß 
and TNFα) in different brain regions between females and males 
 
Figure 8 Effect of chronic restraint stress on Inflammatory markers (IL-1ß and TNFα) mRNA expression in 
(A) Hippocampus, (B) mPFC, (C) Amygdala, (D) Cerebellum. Bars indicate the mean fold changes of 
Inflammatory markers (IL-1ß and TNFα) mRNA relative to male co control group ± s.e.m. after normalizing 
to GAPDH. M-CON: male control group, F-CON: female control group, M-STRESS: male restraint stress 
treated group, F-STRESS: female restraint stress treated group. * indicates significant difference (p < 0.05) in 
male restraint stress treated group TNF-alpha mRNA expression in mPFC compared to male control group. 
$ indicates significant difference (p < 0.05) in CB TNF alpha mRNA expression between sex. N=4 for each 
group. 
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Results:  
The effect of chronic restraint stress on Inflammatory markers (IL-1β and TNFα) 
expression in different brain regions between females and males is summarized in Figure 8. In 
mPFC, two-way ANOVA revealed no significant effects of sex (F[1,11]=0.36, p=0.55), stress 
(F[1,11]=0.34, p=0.56) or stress*sex interaction (F[1,11]=0.61, p=0.45) on IL-1β mRNA 
expression. Two-way ANOVA revealed a significant effect of stress (F[1,11]=11.78, p<0.01), no 
significant effects of sex (F[1,11]=0.18, p=0.67) or stress*sex interaction (F[1,11]=4.79, p=0.05) 
on TNFα mRNA expression. Post hoc analyses suggest that TNFα mRNA in male stress group 
was not significantly different from the female stress group and female control group but were 
significantly lower than in the male control group.  
In cerebellum, two-way ANOVA revealed a significant effect of sex (F[1,11]=18.7, 
p<0.005) and stress*sex interaction (F[1,11]=9.03, p<0.05), no effect of stress (F[1,11]=3.85, 
p=0.07) on IL-1β mRNA expression. Two-way ANOVA revealed a significant effect of sex 
(F[1,11]=5.41, p<0.05), no significant effects of stress (F[1,11]=2.88, p=0.15) or stress*sex 
interaction (F[1,11]=3.62, p=0.08) on TNFα mRNA expression. 
In the hippocampus, two-way ANOVA revealed no significant effects of sex 
(F[1,11]=0.54, p=0.47), stress (F[1,11]=0.14, p=0.71) or stress*sex interaction (F[1,11]=0.35, 
p=0.56) on IL-1β mRNA expression. Two-way ANOVA revealed no significant effects of sex 
(F[1,11]=0.00, p=0.96), stress (F[1,11]=0.26, p=0.62) or stress*sex interaction (F[1,11]=0.90, 
p=0.36) on TNFα mRNA expression.  
In the amygdala, two-way ANOVA revealed no significant effects of sex (F[1,12]=0.06, 
p=0.81), stress (F[1,12]=0.00, p=0.95) or stress*sex interaction (F[1,12]=1.19, p=0.29) on IL-1β 
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mRNA expression. Two-way ANOVA revealed no significant effects of sex (F[1,12]=2.93, 
p=0.11), stress (F[1,12]=0.59, p=0.45) or stress*sex interaction (F[1,12]=1.01, p=0.33) on TNFα 
mRNA expression.  
 
Discussion: 
 The goal of this experiment was to collect data on the effects of chronic restraint stress on 
Inflammatory markers (IL-1β and TNFα) expression in different brain regions between females 
and males. It will provide inference for the effects of chronic restraint stress and sex difference on 
microglial immune responses in the brain.  
Our results indicate that only in cerebellum, chronic restraint stress reduced by 50% levels 
of IL-1β mRNA in stress groups than in control groups in male rats. Therefore, we can see a sex 
difference pattern on IL-1β expression under chronic restraint stress in cerebellum. IL-1β 
expression in males seems to be altered by chronic restraint stress; however, females did not. 
Barnard et. al. [59] showed that male and female rats underwent 4 days of stress exposure or served 
as non-stressed controls. Their findings revealed that stress exposure in male rats affects the 
regulation of brain IL-1β, while stress had no effect in the regulation of brain IL-1β in female rats. 
That is consistent with our data. 
   For TNFα expression, in mPFC and cerebellum, chronic restraint stress respectively 
reduced 50% and 75% levels of TNFα mRNA in stress groups than in control groups in male rats. 
But TNFα expression in female rats in amygdala was increased by 62% exposed to chronic 
restraint stress relative to controls. Overall, we can see that males tend to have a higher response 
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than females in TNFα expression exposure to chronic restraint stress; however, TNFα mRNA 
expression was inhibited by chronic restraint stress in cerebellum and mPFC. 
   There is a review reporting that after exposure to different stressors, cytokine mRNA 
expression patterns in the brain are influenced by sex [60]. Although, circulating cytokines can 
enter the brain through the blood brain barrier, in response to stress, microglia can also be activated 
and release pro-inflammatory cytokines [61]. Increases in pro-inflammatory cytokines exert 
neurotoxic effects on specific brain regions.  
 
 
Our expectation for brain mRNA expression was that chronic restraint stress can 
differentially increase aromatase, estrogen receptors and inflammatory markers mRNA expression 
in females and males. The relative fold changes in mRNAs of inflammatory markers in females 
should be larger than that in males. Since more levels of estrogen could be produced in males 
brain, neuroinflammatory responses can be inhibited by estrogens and thus neurotoxic pro-
inflammatory markers (IL-1β and TNFα) mRNA expression could be lower in males than that in 
females. In that way, the expectation is consistent with our hypothesis. However,  taking results 
from 3.3, Our data provided patterns that under chronic restraint stress, aromatase mRNA 
expression were increased differently between sex. We saw some patterns indicating differences 
existing in sex and treatment in expression of estrogen receptors, but changes were not consistent. 
What’s more, expression of inflammatory markers mRNA (IL-1β and TNFα) were inhibited 
somehow by chronic restraint stress which seems contrary to our expectation.  
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Here we only obtained data from mRNA expression to provide inferences which is not 
comprehensive. We haven’t tested protein production levels of inflammatory markers. The results 
from protein levels might be different from mRNA levels. Therefore additional studies are needed 
to measure protein levels of  inflammatory markers by ELISA or Western Blot. At the same time, 
larger sample sizes also are needed to adequately test the hypothesis.  
  
 
 
  
 50 
3.4 Effects of Chronic Restraint Stress on local E2 production in different brain regions 
 
Figure 9 Effect of chronic restraint stress on local E2 production different brain regions, (A) Hippocampus, 
(B) Amygdala,(C) Cerebellum. Bars indicate the mean E2  levels ± s.e.m. M-CON: male control group, F-
CON: female control group, M-STRESS: male restraint stress treated group, F-STRESS: female restraint 
stress treated group. N=4 for Cerebellum. Every 2 samples were combined and pooled to generate one point 
in Hippocampus and Amygdala (N=2) . 
 
 
Results: 
The effects of chronic restraint stress on levels of local E2 in cerebellum, hippocampus and 
amygdala are summarized in Figure 9. Every two samples were combined and pooled to generate 
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one point in hippocampus and amygdala. E2 levels were higher in the amygdala and hippocampus 
and low in cerebellum. E2 levels in the frontal cortex was below our ability to detect, even though 
we did detect ARO mRNA in this region and combined every two samples to generate one data 
point. In the hippocampus, two-way ANOVA revealed no significant effects of sex (F[1,4]=0.06, 
p=0.80), stress (F[1,4]=0.28, p=0.62) or stress*sex interaction (F[1,4]=1.76, p=0.25) on local E2 
production. In amygdala, two-way ANOVA revealed no significant effects of sex (F[1,4]=1.0, 
p=0.36), stress (F[1,4]=0.83, p=0.41) or stress*sex interaction (F[1,4]=0.04, p=0.83) on local E2 
production. In cerebellum, two-way ANOVA revealed no significant effects of sex (F[1,12]=0.04, 
p=0.83), stress (F[1,12]=0.77, p=0.39) or stress*sex interaction (F[1,12]=0.0, p=0.96) on local E2 
production. 
 
Discussion: 
The goal of this experiment was to collect preliminary data and generate patterns on the 
effects of chronic restraint stress on local estradiol production in different brain regions. The 
sample size is very small (four or two animals each group), so we need more animals in each group 
to generate a meaningful conclusion in statistical analysis. But we still can get some inference 
through patterns between groups in this pilot study, though groups were not significant. 
We did not see any large changes between the four groups. Although there are some 
changes in hippocampus and amygdala, no clear trend is observed. Our expectation is to see that 
sex differences in local E2 production level can be similar with long form ARO expression in the 
brain. If that is true, E2 produced locally in the brain can be associated with sex differences in the 
risk for stress-related brain neuroinflammatory response. Unfortunately, we do not get that result. 
 52 
The sample size in this pilot study is very small and we need additional data to support and examine 
our hypothesis. 
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4.0 SUMMARY AND CONCLUSIONS 
In this study, we developed and validated a method to detect CORT level in rat serum. We 
also tested E2 and T level in rat brain. Few studies reported sex differences in serum CORT levels 
and CORT levels in females respond more to a stressor than in males. Our data support this. We 
need to pay attention to this when developing additional studies. We could minimize the method 
for sacrificing rats. Rats serum E2 levels were undetectable in males and very low, even 
undetectable in females. We think the estrous cycle could account for low E2 levels. But we need 
more studies to confirm. Unfortunately, our analysis of serum T levels failed. This still needs to 
be investigated. 
We have measured changes in the levels of ARO-L, estrogen receptors (ERα, ERβ and 
GPR30) and inflammatory markers (IL-1β and TNFα) mRNA under restraint stress. Our 
expectation for brain mRNA expression was that chronic restraint stress can differently increase 
aromatase, estrogen receptors and inflammatory markers expression in females and males. The 
changes of inflammatory markers in females could be larger than that in males. Our data present a 
pattern suggesting that under chronic restraint stress, aromatase mRNA expression was increased 
differently between sexes. We saw some patterns indicating differences existing in sex and stress 
in expression of estrogen receptors, but changes were not consistent. What’s more, expression of 
inflammatory markers (IL-1ß and TNFα) were lowered in association with chronic restraint stress 
which seems contrary to our expectation. This means that our hypothesis might be wrong. But 
drawing conclusions only from mRNA expression is not complete, we need to test protein levels 
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of inflammatory markers. What’s more, our study is a pilot study and the results are preliminary. 
Our ability to draw conclusions is very limited and more data are needed. 
For local E2 levels in the brain, we expected to see sex differences in local E2 production 
consistent with long form ARO expression in the brain. But results did not support this. We only 
had two data points in each group in most brain regions which was not enough. By comparing 
serum E2 levels with that in brain regions, we can see that ARO activity in brain regions is 
significant and local levels of E2 can greatly exceed circulating levels in both males and females 
which is consistent with previous findings [46]. 
For future study, we have shown some evidence for sex differences in ARO, IL-1ß and 
TNFα mRNA expression as well as specific estrogen receptors. We need to increase sample size 
to further evaluate effects on ARO in the brain in a sexually dimorphic way, affecting local levels 
of estrogen in specific brain regions and resulting in sex differences in neuroinflammatory 
response. 
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